Objective: To observe the clinical efficacy of Busui Shengxue Granule (BSSXG) in chronic aplastic anemia (CAA) and disscuss the differences in expression of signal transduction pathway MAPK before and after treatment. We observe the phosphorylation including ERK1/2, JNK, P38 and the expression of mRNA in bFGF and bFGFR.
Methods: 124 cases of CAA were divided into two groups randomly.There are 61 cases who were used by BSSXG in experimental group,and 63 cases treatmented by Zaizaoshengxue Tablet ...